A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of study BMX-02-001 is to evaluate the safety, tolerability and feasibility of orally administered BX002-A to deliver viable bacteriophages to the gut.
Epistemonikos ID: d7cd7697ddb991d6db27356998dce033203067da
First added on: May 08, 2024